Presentation is loading. Please wait.

Presentation is loading. Please wait.

Dispelling Myths and Misconceptions ACC/AHA 2013 Digoxin Guidelines for Heart Failure.

Similar presentations


Presentation on theme: "Dispelling Myths and Misconceptions ACC/AHA 2013 Digoxin Guidelines for Heart Failure."— Presentation transcript:

1

2

3 Dispelling Myths and Misconceptions

4 ACC/AHA 2013 Digoxin Guidelines for Heart Failure

5 Guidelines From the ADHERE REGISTRY

6 Use of Digoxin in Contemporary Studies and Registries

7 Digoxin Toxicity as an Ongoing Clinical Challenge

8 Digoxin Toxicity

9 Digoxin Toxicity Outcomes

10 Understanding the Pharmacology of Digoxin

11 Digoxin Laboratory Values Survey

12 Signs of Digoxin Toxicity

13

14 Treatment Options

15 Digoxin-specific Antibody Fragments

16 Digoxin-specific Antibody Fragments

17 Acute Life-threatening Digoxin Overdose

18 Digoxin-specific Antibody Fragments

19 Digoxin Toxicity Is Underrecognized!

20 Education and Prevention

21 Digoxin Dosages and Serum Concentrations Nontoxic and Toxic Therapeutic Ranges

22 Key Take-away Points

23 Summary

24 Abbreviations

25 Abbreviations (cont)

26 References

27 References (cont)

28 References (cont)

29 References (cont)


Download ppt "Dispelling Myths and Misconceptions ACC/AHA 2013 Digoxin Guidelines for Heart Failure."

Similar presentations


Ads by Google